top of page

Prostate cancer – A comprehensive overview and treatment options

Treatment options for prostate cancer

Prostate cancer is the most common cancer among men in Europe. The choice of therapy depends on several factors: the tumor stage, aggressiveness (Gleason score), PSA level, possible metastasis, and the patient's overall health.

Thanks to modern diagnostics and diverse treatment options – from active monitoring to surgery and radiation therapy to innovative dendritic cell therapies – the therapy can be individually tailored to the patient.

Prostate cancer dendritic cell therapy IMMUMEDIC Limited.jpg
Flotte

Classic treatment options
in prostate cancer

1. Active Surveillance / Watchful Waiting

Close monitoring may be useful in early, slow-growing tumor stages.
Regular PSA checks, MRI scans and biopsies determine the further course of action.

2. Surgery (radical prostatectomy)

The goal is the complete removal of the prostate.
The surgery is often used for locally confined tumors and, depending on the technique, can be nerve-sparing.

3. Radiation therapy (radiotherapy)

Radiation therapy is used:

  • in locally confined prostate cancer

  • after surgery for residual tumor

  • Pain therapy for bone metastases

Modern methods (IMRT, IGRT) allow for more precise irradiation.

4. Hormone withdrawal therapy (ADT)

Since prostate cancer grows in a hormone-dependent manner, androgen deprivation therapy is often performed.
Goals:

  • Block or lower testosterone

  • slow the growth of the tumor

This includes:

  • LHRH analogues

  • Antihormones

  • Ovarian/testicular suppression

5. Chemotherapy

In advanced stages or in cases of metastases, cytostatic drugs such as docetaxel are used.
These have a systemic effect throughout the entire body.

6. Modern targeted therapies

This includes:

  • PARP inhibitors in BRCA mutations

  • CDK4/6- or PI3K-dependent strategies in molecular alterations

  • Immunomodulating drugs in selected cases

Dendritic cell therapy – modern immunotherapy for prostate cancer

Dendritic cell therapy is a personalized immunotherapy that aims to specifically activate the patient's immune system against tumor cells.

How does dendritic cell therapy work?

  1. Blood draw from the patient

  2. Isolation of monocytes

  3. Cultivation and differentiation into dendritic cells

  4. Loading with tumor antigens (e.g., tumor lysate or defined antigens)

  5. Maturation into highly active dendritic cells

  6. Injection in the patient

The dendritic cells act as “conductors” of the immune system and present tumor characteristics so that T cells are specifically activated against cancer cells.

Combination of classical therapy and DZT

Many patients benefit from combined treatment approaches, e.g.:

  • DZT + Hormone Therapy (ADT)
    → Can support the emerging immune response.

  • DZT + Infusion-based immune system restoration
    (e.g. glutathione, selenium, artesunate, resveratrol)
    → Strengthening the immune system during stressful therapies.

  • DZT + local procedures
    e.g. cryoablation for individual tumor foci

  • DZT + modern systemic therapies
    in cases of genetic mutations or metastatic disease

The goal of DZT in prostate cancer

  • Activation of tumor-directed immune cells

  • Supporting the detection of cancer cells

  • Reduction of tumor burden (varies individually)

  • Stabilization of the immune system

  • Improving disease control

The therapy is individually tailored and can also be a complementary approach in cases of metastatic disease.

Crew

Dendritic cell therapy is a patient-specific immunological approach.

No promises of healing are made.

Legal notice

bottom of page